Table: Takeda Pharma -2025/26 parent results

Takeda Pharmaceutical

13/05/2026 07:34

May 13 (Reuters)- 
          Takeda Pharmaceutical Co. Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            591.60          580.36                                
                 (+1.9 pct)      (-2.6 pct)                              
  Operating         21.14           36.90                                
                 (-42.7 pct)     (-23.2 pct)                             
  Recurring        205.50           86.59                                
                (+137.3 pct)     (-69.8 pct)                             
  Net              197.34          152.82                                
                 (+29.1 pct)     (-54.9 pct)                             
  EPS            125.29 yen       96.79 yen                              
  EPS Diluted    125.26 yen       96.78 yen                              
  Ann Div        200.00 yen      196.00 yen     204.00 yen               
  -Q2 Div        100.00 yen       98.00 yen     102.00 yen               
  -Q4 Div        100.00 yen       98.00 yen     102.00 yen               
  
  NOTE - Takeda Pharmaceutical Co. Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4502.T